Skip to main content
. 2017 Dec 1;8(69):113817–113827. doi: 10.18632/oncotarget.22852

Figure 4. Survival curves of cLNM-neagtive ICC patients (without LND) or pLNM-negative ICC patients (with LND).

Figure 4

(A) OS curves of non-LND patients with cLNM-negative ICC or LND patients with pLNM-negative ICC. There was no significant survival difference between the two groups (p = 0.63). (B) RFS curves of patients with cLNM-negative ICC (without LND) or pLNM-negative ICC (with LND). There was no significant survival difference between the two groups (p = 0.69). Numbers below the graphs show the number of remaining patients at the time point. “cLNM-LND-” represents cLNM-negative patients without LND. “pLNM-LND+” represents patients who underwent LND and were pathologically confirmed as negative for LNM.